These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 20093334)

  • 1. Using activated clotting time to estimate intraoperative aprotinin concentration.
    Iwata Y; Okamura T; Zurakowski D; Jonas RA
    Perfusion; 2009 Nov; 24(6):397-400. PubMed ID: 20093334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Celite and kaolin produce differing activated clotting times during cardiopulmonary bypass under aprotinin therapy.
    Feindt P; Seyfert UT; Volkmer I; Straub U; Gams E
    Thorac Cardiovasc Surg; 1994 Aug; 42(4):218-21. PubMed ID: 7529949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of low doses of aprotinin on clotting times activated with celite and kaolin.
    Farooqi N; De Hert S; Vlaeminck R; De Bakker A; Govaerts E; Vermeyen K
    Acta Anaesthesiol Belg; 1993; 44(3):87-92. PubMed ID: 7508668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro effects of aprotinin on activated clotting time measured with different activators.
    Wang JS; Lin CY; Hung WT; Thisted RA; Karp RB
    J Thorac Cardiovasc Surg; 1992 Oct; 104(4):1135-40. PubMed ID: 1383640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative perioperative anticoagulation monitoring during cardiopulmonary bypass in aprotinin-treated patients.
    Huyzen RJ; Harder MP; Huet RC; Boonstra PW; Brenken U; van Oeveren W
    J Cardiothorac Vasc Anesth; 1994 Apr; 8(2):153-6. PubMed ID: 7515704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aprotinin does not prolong the Sonoclot aprotinin-insensitive activated clotting time.
    Dong Y; Nuttall GA; Oliver WC; Agarwal S; Ereth MH
    J Clin Anesth; 2007 Sep; 19(6):424-8. PubMed ID: 17967670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aprotinin prolongs activated and nonactivated whole blood clotting time and potentiates the effect of heparin in vitro.
    Despotis GJ; Filos KS; Levine V; Alsoufiev A; Spitznagel E
    Anesth Analg; 1996 Jun; 82(6):1126-31. PubMed ID: 8638779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prolonged activated clotting time (ACT) with aprotinin depends on the type of activator used for measurement.
    Wendel HP; Heller W; Gallimore MJ; Bantel H; Müller-Beissenhirtz H; Hoffmeister HE
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):41-5. PubMed ID: 7681331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of MDCO-2010, a serine protease inhibitor, on activated clotting time in blood obtained from volunteers and cardiac surgical patients.
    Kim H; Szlam F; Tanaka KA; van de Locht A; Ogawa S; Levy JH
    Anesth Analg; 2012 Aug; 115(2):244-52. PubMed ID: 22584552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of celite and kaolin on activated clotting time in the presence of aprotinin: activated clotting time is reduced by binding of aprotinin to kaolin.
    Dietrich W; Jochum M
    J Thorac Cardiovasc Surg; 1995 Jan; 109(1):177-8. PubMed ID: 7529346
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of high-dose aprotinin on anticoagulation, heparin requirement, and celite- and kaolin-activated clotting time in heparin-pretreated patients undergoing open-heart surgery. A double-blind, placebo-controlled study.
    Dietrich W; Dilthey G; Spannagl M; Jochum M; Braun SL; Richter JA
    Anesthesiology; 1995 Oct; 83(4):679-89; discussion 29A-30A. PubMed ID: 7574046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of aprotinin on thromboelastography with three different activators.
    Avidan MS; Da Fonseca J; Parmar K; Alcock E; Ponte J; Hunt BJ
    Anesthesiology; 2001 Nov; 95(5):1169-74. PubMed ID: 11684986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the kaolin or celite activated clotting time affected by tranexamic acid?
    Bechtel JF; Prosch J; Sievers HH; Bartels C
    Ann Thorac Surg; 2002 Aug; 74(2):390-3; discussion 393. PubMed ID: 12173818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of aprotinin on activated clotting time, whole blood and plasma heparin measurements.
    Despotis GJ; Joist JH; Joiner-Maier D; Alsoufiev AL; Triantafillou AN; Goodnough LT; Santoro SA; Lappas DG
    Ann Thorac Surg; 1995 Jan; 59(1):106-11. PubMed ID: 7529483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring of heparin-induced anticoagulation with kaolin-activated clotting time in cardiac surgical patients treated with aprotinin.
    Wang JS; Lin CY; Hung WT; Karp RB
    Anesthesiology; 1992 Dec; 77(6):1080-4. PubMed ID: 1281624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The activated clotting time in cardiac surgery: should Celite or kaolin be used?
    De Vries AJ; Lansink-Hartgring AO; Fernhout FJ; Huet RCG; van den Heuvel ER
    Interact Cardiovasc Thorac Surg; 2017 Apr; 24(4):549-554. PubMed ID: 28108578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.
    Ganter MT; Monn A; Tavakoli R; Genoni M; Klaghofer R; Furrer L; Honegger H; Hofer CK
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of temperature and aprotinin during cardiopulmonary bypass on three different methods of activated clotting time measurement.
    Machin D; Devine P
    J Extra Corpor Technol; 2005 Sep; 37(3):265-71. PubMed ID: 16350378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring activated clotting time for combined heparin and aprotinin application: an in vitro evaluation of a new aprotinin-insensitive test using SONOCLOT.
    Ganter MT; Dalbert S; Graves K; Klaghofer R; Zollinger A; Hofer CK
    Anesth Analg; 2005 Aug; 101(2):308-314. PubMed ID: 16037133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a novel kallikrein inhibitor on hemostatic activation in vitro.
    Tanaka KA; Szlam F; Katori N; Vega JD; Levy JH
    Thromb Res; 2004; 113(5):333-9. PubMed ID: 15183046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.